SEP 07, 2021 5:00 AM PDT

Designer Cells for Treating Arthritis Are Activated by Inflammation

WRITTEN BY: Tara Fernandez

Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When implanted into cartilage, these genetically engineered cells mop up an inflammatory cytokine called interleukin-1 (IL-1) and ultimately resist bone erosion.

Over a million adults in the United States are living with rheumatoid arthritis, a chronic autoimmune disorder in which the body’s immune system mistakenly launches an unrelenting attack on the joints. Inflammation, pain, and swelling are hallmarks of the condition, which over time deform joints and significantly impact a patient’s quality of life.

Infusions of anti-inflammatory biologics drugs are currently administered to patients with rheumatoid arthritis. The problem, however, is repeated doses of such treatments can have serious side effects, prompting researchers to consider alternative approaches to addressing uncontrolled joint flare-ups in these patients.

To this end, researchers at the Washington University School of Medicine in St Louis have devised a method for reprogramming stem cells that, once implanted, sense the presence of inflammation and react by releasing a biologic treatment that lowers IL-1 levels in the joint. The therapeutic cells, housed within bioartificial implants, are reprogrammed using CRISPR-Cas9 gene editing. The implants would be placed under the skin or in a joint for months and react when inflammation levels begin to creep up. Administering the cells as an implant ensures the engineered cells stay in place and keep them alive for months.

The research team validated their implant in a mouse model of rheumatoid arthritis and, using advanced imaging techniques, demonstrated that the therapy prevented bone erosion in the animals while keeping inflammation at bay.

According to the researchers, the true value of using a CRISPR-Cas9 approach to engineer these cells is the potential to adapt the treatment to create a personalized medicine approach. In this case, bespoke cell therapies can be created for individual patients based on their responses to the treatment. Such a platform could also benefit the 300,000 children in the United States with a related inflammatory arthritis condition called juvenile arthritis.

 

Sources: Science AdvancesWashington University School of Medicine in St. Louis.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 29, 2021
Immunology
Scientists Discover Bacterial Life on Human Fetuses
JUL 29, 2021
Scientists Discover Bacterial Life on Human Fetuses
A developing fetus in its second trimester of life is changing at an extraordinarily rapid pace––bones are b ...
AUG 26, 2021
Immunology
Sugar-Coating Organs Stops Them From Getting Rejected
AUG 26, 2021
Sugar-Coating Organs Stops Them From Getting Rejected
Once organ failure patients receive the gift of a transplant, they face a life-long threat of immune rejection. Their im ...
SEP 13, 2021
Health & Medicine
How Farming Shaped the Immune System
SEP 13, 2021
How Farming Shaped the Immune System
In today's society, a rural upbringing is associated with a healthier immune system less prone to allergies and auto ...
OCT 07, 2021
Immunology
A 3D-Printed COVID Vaccine Patch?
OCT 07, 2021
A 3D-Printed COVID Vaccine Patch?
Even the bravest souls can get a little nervous when it comes to rolling up their sleeves and getting a shot. Aichmophob ...
OCT 04, 2021
Health & Medicine
Guillain-Barre Syndrome After COVID-19 Infection
OCT 04, 2021
Guillain-Barre Syndrome After COVID-19 Infection
Researchers with the International GBS Outcome Study (IGOS) investigated newly-diagnosed GBS patients from the beginning ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
Loading Comments...